dTDI During a SBT to Predict Extubation Failure in Preterm Infants

Sponsor
Wang Jianhui (Other)
Overall Status
Recruiting
CT.gov ID
NCT05865977
Collaborator
(none)
100
1
10
10

Study Details

Study Description

Brief Summary

Weaning from mechanical ventilation is a critical issue and the diaphragmatic disfunction has been demonstrated to play an important role in extubation failure. the aim of present investigation is to evaluate diaphragmatic excursion velocity during in patients undergoing spontaneous breathing trial through tissue Doppler analysis in both inspiration and expiration.

Condition or Disease Intervention/Treatment Phase
  • Device: diaphragmatic tissue Doppler imaging,dTDI

Study Design

Study Type:
Observational
Anticipated Enrollment :
100 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Diaphragmatic Tissue Doppler Imaging During a Spontaneous Breathing Trial to Predict Extubation Failure in Preterm Infants
Actual Study Start Date :
Feb 25, 2023
Anticipated Primary Completion Date :
Aug 25, 2023
Anticipated Study Completion Date :
Dec 25, 2023

Arms and Interventions

Arm Intervention/Treatment
the failure group

Re-intubation within 48 h after passing the SBT was defined as failed weaning.

Device: diaphragmatic tissue Doppler imaging,dTDI
dTDI was performed at the end of the SBT to assess excursion, velocity, and acceleration.

the success group

Extubation and invasive mechanical ventilation was not needed within 48 h after extubation was defined as successful weaning.

Device: diaphragmatic tissue Doppler imaging,dTDI
dTDI was performed at the end of the SBT to assess excursion, velocity, and acceleration.

Outcome Measures

Primary Outcome Measures

  1. Change in diaphragmatic displacement velocity [an average of 20 minutes]

    Inspiratory and expiratory diaphragmatic displacement velocity evaluated with tissue doppler during the assisted ventilation modality which preceded the trial, during the spontaneous breathing trial and in spontaneous breathing.

Secondary Outcome Measures

  1. Diaphragmatic acceleration and deceleration [an average of 20 minutes]

    Diaphragmatic acceleration and deceleration evaluated with tissue doppler during the assisted ventilation modality which preceded the trial, during the spontaneous breathing trial and in spontaneous breathing.

  2. Gas exchange - arterial carbon dioxide tension [through each trial completion, an average of 20 minutes]

    Arterial blood gases sample

  3. Gas exchange - pH [an average of 20 minutes]

    Arterial blood gases sample

  4. Gas exchange - arterial oxygen tension [an average of 20 min]

    Arterial blood gases sample

  5. Silverman Andersen Respiratory Severity Score (SA-RSS) [an average of 20 min]

    SA-RSS to assess work of breathing after extubation.

  6. Number of patients who experienced weaning failure [48 hours]

    the need for non invasive ventilation or re-intubation due to any cause

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Days to 6 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • premature infants with gestational age <32 weeks and supported by invasive mechanical ventilation ≥48 hours

  • All the indications for extubation are met:cough or vomiting due to spontaneous breathing and sputum aspiration; ventilator parameters in recent 24 hours: MAP < 8cmH2O, RR < 30 times/min, FiO2 < 30%; Arterial blood gas: pH > 7.25, (PaCO2< 60mmHg, BE < 8mmol/L, oxygen saturation > 90%

  • a successful SBT

  • parents or legal guardians sign informed consent to attend this study

Exclusion Criteria:
  • accidental extubation

  • chest CT or bronchoscopy during hospitalization indicated congenital airway dysplasia

  • complex congenital heart disease

  • congenital metabolic diseases, neuromuscular diseases

  • severe brain injury

  • surgical mechanical ventilation

  • give up before extubation;

  • pneumothorax or pleural effusion

  • no consent is signed

Contacts and Locations

Locations

Site City State Country Postal Code
1 Children's hospital of Chongqing Medical University Chongqing Chongqing China 400014

Sponsors and Collaborators

  • Wang Jianhui

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Wang Jianhui, Attending doctor, Children's Hospital of Chongqing Medical University
ClinicalTrials.gov Identifier:
NCT05865977
Other Study ID Numbers:
  • 20230223
First Posted:
May 19, 2023
Last Update Posted:
May 19, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Wang Jianhui, Attending doctor, Children's Hospital of Chongqing Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 19, 2023